(R)-3-Amino-1-Butanol CAS 61477-40-5 Ukuhlanzeka >99.0% (GC) I-Dolutegravir Intermediate Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-3-Amino-1-Butanol (CAS: 61477-40-5) with high quality, commercial production. It's an intermediate of Dolutegravir (CAS: 1051375-16-6). We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available, strong after-sale service. Please contact: alvin@ruifuchem.com
Igama Lekhemikhali | (R)-3-Amino-1-Butanol |
Omqondofana | (R)-3-Aminobutan-1-ol;(3R)-3-Amino-1-Butanol |
Inombolo ye-CAS | 61477-40-5 |
Inombolo yeCAT | I-RF-CC317 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | C4H11NO |
Isisindo samangqamuzana | 89.14 |
I-Gravity ethize (20/20) | 0.95 |
I-Refractive Index | 1.45 |
Ukuzungezisa Okuthile [α]20/D | -12.0° ~ -10.0° (C=1, EtOH) |
Ibhrendi | I-Ruifu Chemical |
Ukubukeka | Uketshezi Olungenambala Kuya Kuphuzi Olukhanyayo | Uketshezi Oluphuzi Olukhanyayo |
Ukuhlonzwa nge-IR | Ihambisana Ne-Spectrum Yezinga | Kuyavumelana |
Ukuhlonzwa ngu-GC | Ivumelana Nesikhathi Sokugcina Sezinga | Kuyavumelana |
Ukuhlanzeka ngo-GC (A%) | >99.0% | 99.8% |
Izinto Ezihlobene | Noma Ikuphi Ukungcola Okukodwa: <0.5% | 0.09% |
Ukungcola Okuphelele: <1.0% | 0.28% | |
I-S-Isomer (nge-HPLC A%) | <0.10% | 0.02% |
Okuqukethwe Amanzi ngu-KF | <0.50% | 0.10% |
I-Assay ngo-GC (w/w%) | >99.0% | 99.3% |
Iphakheji: Ibhodlela Elifakwe Fluorinated, 25kg/Drum, noma ngokwezidingo zekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
(R) -3-Amino-1-Butanol (CAS: 61477-40-5) ingasetshenziswa njengendawo ephakathi ekulungiseleleni izinhlanganisela ezine-HIV integrase inhibitory umsebenzi.(R)-3-Amino-1-Butanol iphakathi kwe-Dolutegravir (CAS: 1051375-16-6).I-Dolutegravir (Tivicay) kwakuwuhlobo olusha lomuthi olwa ne-ADIS olwakhiwa ngokuhlanganyela umdondoshiya wemithi yaseBrithani i-GlaxoSmithKline (GSK) ne-Japan Shionogi Pharmaceutical Company (Shionogi).Ngo-Agasti 2013, i-US FDA igunyaze i-dolutegravir (ebuye ibizwe nge-S/GSK1349572) yokwelapha ukutheleleka nge-HIV-1 kubantu abadala nasezinganeni ezineminyaka engu-12 nangaphezulu ngokuhlangana neminye imithi yezidambisigciwane.